GENESIS HEALTHCARE V. BECERRA

A two-part deep dive into one of the most important and contentious areas of the 340B program. While much of the 340B community’s attention has been focused on the contract pharmacy suits winding through the federal court system, there is other activity that the federal court system is grappling with that one could argue is equally or even more important. A federal appeals court is his hearing arguments challenging one of the 340B program’s bedrock principles—the definition of a “patient” eligible to receive 340B drugs. 340B Report takes a close look at the groundbreaking case’s influence over the government’s position on patient definition and its far-reaching implications.

340B Patient Definition Is at the Heart of Case Debated Before Federal Appeals Court

In Federal Genesis, Judicial, Special Reports April 07, 2022

Tom Mirga

A health center asked a federal appeals court in Richmond, Va., last month to reverse a lower court decision that left the longstanding 340B program definition of “patient” in effect.

While All Eyes are on 340B Contract Pharmacy Battle, Federal Appeals Court Hears Arguments in Key Case Challenging HRSA’s Patient Definition

In Federal Genesis, Judicial, Special Reports April 05, 2022

Tom Mirga

A federal appeals court heard arguments last month in a South Carolina health center’s lawsuit challenging one of the 340B program’s bedrock principles—the definition of a “patient” eligible to receive 340B drugs.

GENESIS HEALTHCARE V. BECERRA

340B Patient Definition Is at the Heart of Case Debated Before Federal Appeals Court

While All Eyes are on 340B Contract Pharmacy Battle, Federal Appeals Court Hears Arguments in Key Case Challenging HRSA’s Patient Definition

Site Footer